Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cogene Ventures, also known as Cogene Biotech Ventures, was a Houston-based venture capital firm that specialized in early-stage investments within the life sciences and biotechnology sectors. Founded in 2000 by the renowned geneticist C. Thomas Caskey, the firm focused on identifying and supporting companies that utilized genomic and proteomic technologies for drug discovery and medical diagnostics. Cogene Ventures managed multiple funds, including Cogene Biotech Ventures Fund and Cogene Biotech Ventures II, and built a portfolio that featured notable companies such as MacroGenics, Athersys, and Targacept. The firm played a significant role in the development of the biotechnology industry in Texas and the Southeastern United States. Cogene Ventures is no longer active, having liquidated its funds and ceased operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cogene Ventures.